ANALYSIS OF METHOTREXATE AND 7-HYDROXYMETHOTREXATE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND PRELIMINARY CLINICAL-STUDIES

被引：22
作者：
COLLIER, CP
MACLEOD, SM
SOLDIN, SJ
机构：
[1] HOSP SICK CHILDREN, INST RES, DEPT BIOCHEM, TORONTO M5G 1X8, ONTARIO, CANADA
[2] UNIV TORONTO, DEPT CLIN BIOCHEM, TORONTO M5S 1A1, ONTARIO, CANADA
[3] UNIV TORONTO, DEPT PHARMACOL, TORONTO M5S 1A1, ONTARIO, CANADA
来源：
THERAPEUTIC DRUG MONITORING | 1982年 / 4卷 / 04期
关键词：
D O I：
10.1097/00007691-198212000-00007
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：371 / 380
页数：10
相关论文
共 26 条
[11]  
HUFFMAN DH, 1973, CLIN PHARMACOL THER, V14, P572
[12]  
ISACOFF W H, 1976, Medical and Pediatric Oncology, V2, P319, DOI 10.1002/mpo.2950020313
[13]   7-HYDROXYMETHOTREXATE AS A URINARY METABOLITE IN HUMAN SUBJECTS AND RHESUS-MONKEYS RECEIVING HIGH DOSE METHOTREXATE [J].
JACOBS, SA ;
STOLLER, RG ;
CHABNER, BA ;
JOHNS, DG .
JOURNAL OF CLINICAL INVESTIGATION, 1976, 57 (02) :534-538
[14]   HIGH-PRESSURE LIQUID-CHROMATOGRAPHY ANALYSIS OF METHOTREXATE POLYGLUTAMATES IN CULTURED HUMAN-BREAST CANCER-CELLS [J].
JOLIVET, J ;
SCHILSKY, RL .
BIOCHEMICAL PHARMACOLOGY, 1981, 30 (11) :1387-1390
[15]   RAPID, RADIOCHEMICAL LIGAND BINDING ASSAY FOR METHOTREXATE [J].
KAMEN, BA ;
TAKACH, PL ;
VATEV, R ;
CASTON, JD .
ANALYTICAL BIOCHEMISTRY, 1976, 70 (01) :54-63
[16]   THE ROLE OF 7-HYDROXYMETHOTREXATE DURING METHOTREXATE ANTI-CANCER THERAPY [J].
LANKELMA, J ;
VANDERKLEIN, E ;
RAMAEKERS, F .
CANCER LETTERS, 1980, 9 (02) :133-142
[17]   RAPID AND SIMPLE METHOD FOR THE MEASUREMENT OF METHOTREXATE AND 7-HYDROXYMETHOTREXATE IN SERUM BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
LAWSON, GJ ;
DIXON, PF ;
AHERNE, GW .
JOURNAL OF CHROMATOGRAPHY, 1981, 223 (01) :225-231
[18]  
MARTY JJ, 1979, CLIN EXP PHARMACOL P, P29
[19]   EFFECT OF URINE PH AND FLOW ON RENAL CLEARANCE OF METHOTREXATE [J].
SAND, TE ;
JACOBSEN, S .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 19 (06) :453-456
[20]   CLINICAL PHARMACOKINETICS OF METHOTREXATE [J].
SHEN, DD ;
AZARNOFF, DL .
CLINICAL PHARMACOKINETICS, 1978, 3 (01) :1-13
123